Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;7(7):E896-E903.
doi: 10.1055/a-0889-7743. Epub 2019 Jul 3.

Safety and efficacy of digital single-operator pancreatoscopy for obstructing pancreatic ductal stones

Affiliations

Safety and efficacy of digital single-operator pancreatoscopy for obstructing pancreatic ductal stones

Olaya I Brewer Gutierrez et al. Endosc Int Open. 2019 Jul.

Abstract

Background and study aims The role of the digital single-operator pancreatoscopy (D-SOP) with electrohydraulic (EHL) or laser lithotripsy (LL) in treating pancreatic ductal stones is unclear. We investigated the safety and efficacy of D-SOP with EHL or LL in patients with obstructing pancreatic duct stones. Patients and methods Retrospective analysis of 109 patients who underwent D-SOP for pancreatic stones at 17 tertiary centers in the United States and Europe from February 2015 to September 2017. Logistic regression was performed to identify factors associated with the need for more than one D-SOP with EHL/LL. Results Most patients were males (70.6 %),mean age 54.7 years. Fifty-nine (54.1 %) underwent EHL and 50 (45.9 %) underwent LL. Mean procedure time was longer in the EHL group (74.4 min vs 53.8 min; P < 0.001). Ducts were completely cleared (technical success) in 89.9 % of patients (94.1 % in EHL vs 100 % in LL; P = 0.243), achieved in a single session in 73.5 % of patients (77.1 % by EHL and 70 % by LL; P = 0.5).D-SOP failed in 11 patients (10.1 %); 6 patients were treated with extracorporeal shockwave lithotripsy (ESWL), 1 with surgery,1 with combined treatment (ESWL + D-SOP EHL) and 3 with other. Fourteen adverse events occurred in 11 patients (10.1 %). Patients with more than three ductal stones were more likely to have technical failure compared to those with less than three stones (17 % vs. 4.8 %; P = 0.04). Having more than three stones was independently associated with the need for more than one D-SOC EHL/LL session (OR 2.94, 95 % CI 1.13 – 7.65). Conclusion D-SOP with EHL or LL is effective and safe in patients with pancreatic ductal stones.

PubMed Disclaimer

Conflict of interest statement

Competing interests Dr. Raijman is a consultant and speaker for Boston Scientific and Covidien and co-owner of EndoRx. Dr. Shah is consultant for Cook and for Boston Scientific. Dr. Webster is a consultant for Boston Scientific. Dr. Pleskow is a consultant for Boston Scientific, Olympus and Medtronic. Dr. Sherman is a consultant for Boston Scientific. Dr. Sturgess has received financial support from Boston Scientific to attend scientific meetings. Dr. Sejpal is a consultant for Boston Scientific, Olympus, and Ninepoint. Dr. Adler is a consultant for Boston Scientific. Dr. Mullady is a consultant for Boston Scientific and speaker for Abbvie. Dr. DiMaio is a consultant for Boston Scientific. Dr. Sharahia is a consultant for Boston Scientific and Apollo Endosurgery. Dr. Han has received NIH training grant (NIH T32DK007038). Dr. Bekkali has received a travel grant to attend UEGW 2016 from Boston Scientific. Dr. Wang has received research support from Cook Medical. Dr. Carr-Locke is a consultant for Boston Scientific and shares royalty from Steris and Telemed. Dr. Kumbhari is a consultant for Boston Scientific, ReShape Life Sciences, Apollo Endosurgery and Medtronic. Dr. Singh is a consultant for Abbvie, Akcea Therapeutics, and Ariel Precision Medicine. Dr. Khashab is a consultant for Boston Scientific, Olympus and Medtronic and is on the medical advisory board for Boston Scientific and Olympus.

Figures

Fig. 1
Fig. 1
63-year-old female with history of alcohol induced chronic pancreatitis. Patient has recurrent post prandial abdominal pain. CT scan showed dilated MPD with stones. a ERCP showing a dilated, tortuous MPD with multiple filling defects at the genu/body. b Intraductal pancreatic stone seen on pancreatoscopy. c Ho:YAG lasers’ probe green light on the surface of the stone. d Final ERCP pancreatogram showing decompressed MPD without filling defects.
Fig. 2
Fig. 2
33-year-old male with recurrent acute on chronic pancreatitis secondary to heterozygous SPINK1 N34S mutation. On CT scan, a stone located in the MPD at the level of the pancreatic body with upstream ductal dilation was noted. a ERCP showed a mildly dilated and tortuous MPD with side branches widening. The distal body/tail is not visualized despite high quality pancreatogram and attempts to pass the wire distally were unsuccessful. b The pancreatoscope was advanced over the wire to the area that was not well visualized. c A round stone was seen on pancreatoscopy. EHL probe advanced. d Fragments of the stone post lithotripsy.

References

    1. Beyna T, Neuhaus H, Gerges C. Endoscopic treatment of pancreatic duct stones under direct vision: Revolution or resignation? Systematic review. Dig Endosc. 2018;30:29–37. - PubMed
    1. Díte P, Ruzicka M, Zboril V et al. A prospective, randomized trial comparing endoscopic and surgical therapy for chronic pancreatitis. Endoscopy. 2003;35:553–558. - PubMed
    1. Tandan M, Talukdar R, Reddy D N. Management of pancreatic calculi: an update. Gut Liver. 2016;10:873–880. - PMC - PubMed
    1. Dumonceau J M, Costamagna G, Tringali A et al. Treatment for painful calcified chronic pancreatitis: extracorporeal shock wave lithotripsy versus endoscopic treatment: a randomized controlled trial. Gut. 2007;56:545–552. - PMC - PubMed
    1. ASGE Technology Committee . Komanduri S, Thosani N et al. Cholangiopancreatoscopy. Gastrointest Endosc. 2016;84:209–221. - PubMed